N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma

Clinical and Experimental Dermatology

Volumn 38, Issue 4, 2013, Pages 403-409

  Zhou, C F ^a   Yu, J F ^a   Zhang, J X ^a   Jiang, T ^a   Xu, S H ^a   Yu, Q Y ^a   Zhu, Q X ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BLEOMYCIN; CATALASE; HYDROXYPROLINE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN CONTENT; SCLERODERMA; SKIN FIBROSIS;

ACETYLCYSTEINE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CATALASE; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; FREE RADICAL SCAVENGERS; INJECTIONS, SUBCUTANEOUS; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SCLERODERMA, LOCALIZED; SKIN; SUPEROXIDE DISMUTASE; THIOBARBITURATES;

EID: 84876723249     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12033     Document Type: Article

References (25)

1. Jinnin M,. Mechanisms of skin fibrosis in systemic sclerosis. J Dermatol 2010; 37: 11-25.
2. Abraham DJ, Krieg T, Distler J, et al,. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxf) 2009; 48: iii3-7.
3. Sambo P, Baroni SS, Luchetti M, et al,. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001; 44: 2653-64.
4. Ogawa F, Shimizu K, Muroi E, et al,. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. Rheumatology (Oxford) 2006; 45: 815-18.
5. Avouac J, Borderie D, Ekindjian OG, et al,. High DNA oxidative damage in systemic sclerosis. J Rheumatol 2010; 37: 2540-7.
6. Servettaz A, Goulvestre C, Kavian N, et al,. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 2009; 182: 5855-64.
7. Yamamoto T, Takagawa S, Katayama I, et al,. Animal model of sclerotic skin. I. Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999; 112: 456-62.
8. Yamamoto T,. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis? Arch Dermatol Res 2006; 297: 333-44.
9. Inghilleri S, Morbini P, Oggionni T, et al,. In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis. Histochem Cell Biol 2006; 125: 661-9.
10. Hagiwara SI, Ishii Y, Kitamura S,. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med 2000; 162: 225-31.
11. Manoury B, Nenan S, Leclerc O, et al,. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir Res 2005; 6: 11.
12. Srivastava RK, Rahman Q, Kashyap MP, et al,. Ameliorative effects of dimetylthiourea and N-acetylcysteine on nanoparticles induced cyto-genotoxicity in human lung cancer cells-a549. PLoS ONE 2011; 6: e25767.
13. Cortijo J, Cerda-Nicolas M, Serrano A, et al,. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J 2001; 17: 1228-35.
14. Serrano-Mollar A, Closa D, Cortijo J, et al,. P-selectin upregulation in bleomycin induced lung injury in rats. effect of N-acetyl-L-cysteine. Thorax 2002; 57: 629-34.
15. Yildirim Z, Kotuk M, Iraz M, et al,. Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine. Pulm Pharmacol Ther 2005; 18: 367-73.
16. Qiao J, Zhang M, Bi J, et al,. Pulmonary fibrosis induced by H5N1 viral infection in mice. Respir Res 2009; 10: 107-15.
17. Draper HH, Hadley M,. Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol 1990; 186: 421-31.
18. Levine RL, Garland D, Oliver CN, et al,. Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 1990; 186: 464-78.
19. Liu Z, Sun L, Zhu L, et al,. Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. J Neurochem 2007; 103: 2690-700.
20. Wang D, Li Y, Hou G, et al,. Pygeum africanum: effect on oxidative stress in early diabetes-induced bladder. Int Urol Nephrol; 2010; 42: 401-8.
21. Rosato E, Rossi C, Molinaro I, et al,. Long-term N-acetylcysteine therapy in systemic sclerosis interstitial lung disease: a retrospective study. Int J Immunopathol Pharmacol 2011; 24: 727-33.
22. Yoshizaki A, Iwata Y, Komura K, et al,. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 2008; 172: 1650-63.
23. Ishikawa H, Takeda K, Okamoto A, et al,. Induction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4 + T cells. J Invest Dermatol 2009; 129: 1688-95.
24. Falanga V, Martin TA, Takagi H, et al,. Low oxygen tension increases mRNA levels of alpha-1 procollagen in human dermal fibroblasts. J Cell Physiol 1993; 157: 408-12.
25. Bowler RP, Nicks M, Warnick K, et al,. Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2002; 282: L719-26.